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Hydrosalpinges have been associated with poor in-vitro
fertilization (IVF) outcome in some, but not all, studies,
perhaps through endometrial effects. To determine
whether hydrosalpinges affect IVF outcome via endometrial
factors alone, we analysed the results of recipients of
donor oocytes with hydrosalpinges, thereby controlling
for confounding variables, while isolating the intrauterine
environment. We retrospectively analysed 110 patients who
underwent 121 donor oocyte cycles in a university-based
assisted reproduction programme. Thirteen cycles involving
recipients (n J 10) with hydrosalpinges were compared to
108 cycles involving recipients (nJ 100) without hydro-
salpinges. Pregnancy, implantation, miscarriage, and
ectopic pregnancy rates were compared between women
with and without hydrosalpinges. There were no significant
differences between the hydrosalpinx and no hydrosalpinx
groups with respect to donor age, recipient age, or number
or grade of embryos transferred. Patients with a hydro-
salpinx had significantly lower embryo implantation rates
(7.1 versus 19.3%, P < 0.05) and significantly higher
miscarriage (75.0 versus 14.9%,P < 0.05) and ectopic
pregnancy rates (33.3 versus 0.0%,P < 0.05) than normal
controls. We conclude that the presence of a hydrosalpinx
adversely affects early pregnancy events by altering the
intrauterine environment.
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Introduction
Several studies have shown an association between the presence
of a hydrosalpinx and poor in-vitro fertilization (IVF) outcome
(Andersenet al., 1994; Kassabjiet al., 1994; Strandellet al.,
1994; Vandromme t al., 1995; Katzet al., 1996; Fleming and
Hull, 1996; Blazeret al., 1997). Akmanet al. demonstrated a
similar effect in cryopreserved embryos as well (Akmanet
al., 1996). Various theories have been proposed to explain this
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phenomenon. Shararaet al.suggested that chronic endometritis
due to the same organism that caused the hydrosalpinx (i.e.
Chlamydia trachomatis) leads to altered endometrial receptivity
(Shararaet al., 1996). Others proposed that the initial infection
permanently damaged the endometrium (Strandellet a ., 1994).
Mansouret al.postulated that reflux of fluid into the endomet-
rial cavity could hinder implantation (Mansouret al., 1991).
Retrograde spillage may also be embryotoxic (Mukherjeeet al.,
1996) or alter endometrial receptivity (Meyert al., 1997).
Alternatively, ovarian stimulation increases the fluid volume
within the Fallopian tube (Mansouret al., 1991). Natural cycle
IVF may decrease the fluid volume within the Fallopian tube
and improve IVF success rates (Lindheimet al., 1997).
Furthermore, hydrosalpinges may secrete cytokines that
adversely affect pregnancy outcome (Grifoet al., 1989; Toth
et al., 1992), through reflux of fluid, or via haematogenous or
lymphatic routes.
Prior studies examining the effect of hydrosalpinges on IVF
cycles have employed autologous oocytes. Using a donor
oocyte model we sought to control for confounding variables,
such as ovarian and uterine senescence, male factor, embryo
quality and number, and the ovarian stimulation protocol with
its effect on the endometrium. In this manner we effectively
isolated the intrauterine environment so as to analyse early
implantation events more accurately.
Materials and methods
A retrospective analysis of cycles (n 5 13) was performed in 10
patients with hydrosalpinges and normal semen analyses undergoing
IVF with donated oocytes in a university-based assisted reproduc-
tive programme. The presence of a hydrosalpinx was determined
using either transvaginal ultrasonography or hysterosalpingography.
These patients were then compared to others undergoing IVF with
donated oocytes without hydrosalpinges and normal semen analyses
(n 5 100; 108 cycles).
Oocyte donors underwent ovarian stimulation with follicle stimulat-
ing hormone (FSH) and were monitored by transvaginal ultrasound
and serum oestradiol concentrations (Sauer, 1995). When the follicles
reached 18–20 mm, human chorionic gonadotrophin (HCG) was
given to trigger ovulation. Thirty-six hours later follicles were
aspirated transvaginally under ultrasound guidance. The oocytes were
then incubated with spermatozoa. Fertilization was documented, and
resulting embryos were transcervically transferred after 2 or 3 days
to the recipient’s uterus. Recipients were carefully synchronized with
the donors to ensure the endometrium was appropriately primed for
implantation. Synchronization was achieved with exogenous oestrogen
and progesterone supplementation. Nine and 12 days after embryo
transfer the patient was tested for pregnancy with serum HCG.
The two study groups were analysed for donor and recipient age,





















Table I. Results of donor oocyte in in-vitro fertilization cycles
Hydrosalpinx No hydrosalpinx
Number of patients 10 100
Number of embryo transfers 13 108
Pregnancy rate/embryo transfer (%) 46.2 (6/13) 45.4 (49/108)
Implantation rate/embryo transferreda (%) 7.1 (4/56) 19.3 (87/452)
Ongoing pregnancy rate/embryoa (%) 1.8 (1/56) 16.4 (74/452)
Ongoing pregnancy rate/embryo transfera (%) 7.7 (1/13) 39.8 (43/108)
Ectopic rate/pregnancya (%) 33.3 (2/6) 0.0 (0/87)
Miscarriage rate/implantation eventa (%) 75.0 (3/4) 14.9 (13/87)
aP value, 0.05.
comes included gross pregnancy rates (a positiveβ-HCG) and
ongoing pregnancy rates (a documented fetal heart rate), as well as
implantation, miscarriage, and ectopic pregnancy rates. The embryo
implantation rate included only known intrauterine pregnancies.
The ongoing pregnancy rate included only intrauterine pregnancies
progressing beyond 12 weeks gestational age.
Statistics were performed with the SPSS statistical package.χ2 and
Fisher’st-test were used. Significance was defined as aP v lue, 0.05.
Results
Results are shown in Table I. The hydrosalpinx group had a
gross pregnancy rate similar to the group without hydro-
salpinges. However, the implantation rate per embryo trans-
ferred in the hydrosalpinx group was significantly lower
(P, 0.05) than the group without hydrosalpinges. Furthermore,
the ectopic pregnancy rate and the miscarriage rate were
significantly higher (P, 0.05) in women with hydrosalpinges.
The ongoing pregnancy rate per embryo was significantly
lower (P , 0.05) in those with hydrosalpinges as was the
ongoing pregnancy rate per cycle. There were no significant
differences between patients with hydrosalpinges and without
hydrosalpinges related to donor age, recipient age, or number
or grade of embryos transferred.
Discussion
In reviewing the data it is apparent that outcomes of donor
oocyte cycles are negatively affected by the presence of a
hydrosalpinx in the recipient. The initial pregnancy rates of
the two groups studied were similar. However, women with
hydrosalpinges had more ectopic pregnancies (P, 0.05),
more miscarriages (P, 0.05), and a lower ongoing pregnancy
rate (P, 0.05). All of these observations lessened the overall
delivery rate of these patients, principally as a result of
increased pregnancy wastage.
This study is unique in using a donor oocyte model to
focus on the intrauterine environment. This model allows the
dissociation of the donor’s gametogenesis and steroidogenesis
from the recipient’s inherent endometrial receptivity and has
been employed before to study isolated parameters that affect
IVF outcome such as male factor (Gallardoet al., 1996)
and ovarian and uterine senescence (Sauer, 1997). Because
extrauterine factors were controlled for in this study, the
adverse events appear to be mediated through alterations of
the recipient’s intrauterine environment.
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The early survival of embryos and their ability to express
HCG does not appear to be impaired in our study. In fact the
presence of two ectopic gestations in the hydrosalpinx group
underscores the notion that the tubal fluid itself is not
embryotoxic. Deleterious effects are most apparent after weeks
of observation, not days, which may reflect chronic endometrial
changes rather than acute embryotoxic causes.
In the past we encountered few recipients with hydro-
salpinges. More recently the indications for donor IVF have
been expanded to include poor responders (Remohiet al.,
1993) and failed IVF (Burtonet al., 1993). Thus, we are
noting a larger percentage of hydrosalpinges in this population.
This study confirms the deleterious effects of hydrosalpinges
on IVF pregnancy rates. This effect is noted after weeks and
suggests a chronic rather than acute process, which may
r flect a chronic alteration of the endometrium rather than an
embryotoxic effect of the tubal fluid. In our practice, patients
are offered salpingectomy to remove the source of the noxious
fluid. Although Sheltonet al. (Shelton et al., 1996) have
reported improved IVF outcome after salpingectomy, this
approach still awaits controlled randomized trials to prove
fficacy. Simply removing diseased Fallopian tubes may not
reverse the chronic endometrial changes that lead to this
phenomenon. Freemanet al. (Freemanet al., 1998) also noted
an improvement in pregnancy outcome after salpingectomy,
although a significant impairment of implantation remained.
In addition, embryos that were not transferred were at greater
risk of growth arrest and degeneration, suggesting a deleterious
effect of the hydrosalpinx on the ovary as well. One possible
alternative to salpingectomy is aspiration of the hydrosalpinx
prior to IVF, which has shown benefit in some small series of
patients (Russellet al., 1991; Van Voorhiset al., 1998).
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